Integrated Single-Cell and Spatial Analysis Reveals a Metabolic-Immune Axis Driving Aortic Dissection

Jing Tao1,2, Huanjie Yang3,4, Jiahui Yong1,2

  • 1Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.

Summary

Aortic dissection (AD) risk increases with fibroblast loss and vascular smooth muscle cell (vSMC) reprogramming. Targeting ENO1 may reduce inflammation and slow AD progression, offering potential therapeutic strategies.